We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Medical News & Perspectives |

Using Ventricular Assist Devices as Long-term Therapy for Heart Failure

Andrew A. Skolnick
JAMA. 1998;279(19):1509-1510. doi:10.1001/jama.279.19.1509.
Text Size: A A A
Published online


A MULTICENTER clinical trial will soon begin recruiting patients to see if ventricular assist devices (VADs) are an effective long-term treatment for patients with advanced congestive heart failure (CHF).

Although these implantable heart assist pumps are being used as a short-term "bridge to transplantation"—keeping patients with end-stage heart disease alive until a donor organ can be obtained—they have not been approved for long-term therapy.

The randomized, nonblinded, controlled trial, called REMATCH (for Randomized Evaluation of Mechanical Assistance and Treatment of Congestive Heart Failure), will seek to determine whether VADs and medical treatment are clearly superior to optimum medical treatment alone in improving patient survival and quality of life, said Eric A. Rose, MD, Valentine Mott/Johnson & Johnson Professor of Surgery and chair of the Department of Surgery at Columbia University's College of Physicians and Surgeons, in New York, NY.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

3 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Palliative Care for Patients With Heart Failure

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Heart Failure